Astellas Pharma - ALPMY Short Interest Ratio & Short Volume

Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 44,300 shares of ALPMY short. Learn More on Astellas Pharma's current short interest.

Astellas Pharma saw a drop in short interest in March. As of March 15th, there was short interest totaling 44,300 shares, a drop of 15.8% from the previous total of 52,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Astellas Pharma: Horizon Therapeutics Public Limited (1.43%), Genmab A/S (0.44%), Genmab A/S (0.07%), Alnylam Pharmaceuticals, Inc. (4.34%), MERCK Kommanditgesellschaft auf Aktien (0.16%), BeiGene, Ltd. (1.94%), BioMarin Pharmaceutical Inc. (3.99%), UCB SA (0.30%), Catalent, Inc. (3.04%), and Sarepta Therapeutics, Inc. (9.18%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is March, 15 2023.